Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G/A for MONOPAR THERAPEUTICS INC Common Stock (MNPR).
- Disclosed ownership: 17%.
- Date of event: 31 Dec 2024.
JANUS HENDERSON GROUP PLC - 31 Dec 2024 SCHEDULE 13G/A Report for MONOPAR THERAPEUTICS INC Common Stock (MNPR)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Symbol
- MNPR
- Shares outstanding
- 6,086,622 shares
- Disclosed Ownership
- 1,046,899 shares
- Ownership
- 17%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 Jan 2025, 11:38:00 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 14 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 17% ownership in MONOPAR THERAPEUTICS INC Common Stock (MNPR) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 Jan 2025, 11:38.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 17% | 1,046,899 | 0 | 1,046,899 | Kristin Mariani | Head of North America Compliance, CCO | |
| Janus Henderson Biotech Innovation Master Fund Ltd | 16% | 952,829 | 0 | 952,829 | Kristin Mariani | Head of North America Compliance, CCO |